Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
This intro explains key decision criteria for choosing Pow over Pos, focusing on security, efficiency, and ecosystem maturity.
22,810 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Bitcoin is testing new support near $60,000 as Strategy Shares hover below the $100 mark. This dual move highlights h...
The FHFA proposes an outcome-based Duty to Serve overhaul to push Fannie Mae and Freddie Mac toward stronger support ...
In a challenging crypto bear market, XRP and Dogecoin face different hurdles and opportunities. This guide breaks dow...
Micron Technology unveiled long-term contracts totaling about $100 billion in minimum revenue through 2030, sending s...
Caterpillar rides a surge in backlog and AI-driven demand, yet analysts stay cautious as the stock nears record highs...
Investors are watching a rising probability federal reserve rate move, a signal that everyday market dynamics could s...
Oracle's AI strategy is under scrutiny as earnings shed light on backlog and cash needs. We see roughly 46-47% upside...
Australia moves to empower its online safety watchdog and raise penalties for breaches of the under-16 social media b...
A near-10-year divorce can erase months of divorced-spouse Social Security benefits. The calendar, not sentiment, det...
A Ramsey segment this week urges retirees to consider Roth conversions to sidestep the 10-year inherited IRA trap, po...
Cantor Fitzgerald's drastic price-target increase for Intel signals strong AI infrastructure conviction. Investors, h...